| RS2144020025 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS2144020781 |
FOXC2
|
Health Risk |
Likely pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS2144025582 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144026030 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144026061 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144026301 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144026600 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144026762 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144027139 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144027729 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144035068 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144035234 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS2144035251 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144036802 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2144041488 |
FKBP10
|
Health Risk |
Pathogenic |
Bruck syndrome 1, Bruck syndrome 1 |
| RS2144041758 |
FKBP10
|
Health Risk |
Likely pathogenic |
Bruck syndrome 1, Bruck syndrome 1 |
| RS2144041940 |
MYO5B
|
Health Risk |
Pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS2144044038 |
RAD51C
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2144044105 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2144044910 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2144045743 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS2144046795 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2144047886 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS2144048741 |
MYO5B
|
Health Risk |
Pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS2144052934 |
FKBP10
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 11, Osteogenesis imperfecta type 11 |
| RS2144059286 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144060112 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2144060132 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144060353 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2144060522 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144063401 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2144069621 |
FKBP10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bruck syndrome 1, Bruck syndrome 1 |
| RS2144072645 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2144074254 |
ZFHX3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2144077500 |
DSG1
|
Health Risk |
Pathogenic |
— |
| RS2144077639 |
DNAI2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144080241 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2144080315 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2144080858 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2144083830 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144087861 |
WNK4
|
Health Risk |
Likely pathogenic |
Pseudohypoaldosteronism type 2B, Pseudohypoaldosteronism type 2B |
| RS2144091452 |
DSG1
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma i, striate |
| RS2144092407 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS2144093084 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144093507 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2144093610 |
DSG1
|
Health Risk |
Likely pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS2144094044 |
MYO5B
|
Health Risk |
Pathogenic |
— |
| RS2144094082 |
MYO5B
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2144094448 |
BRIP1
|
Health Risk |
Likely pathogenic |
— |
| RS2144094505 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2144095211 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144098983 |
DSG1
|
Health Risk |
Pathogenic |
— |
| RS2144105381 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144107587 |
DSG1
|
Health Risk |
Likely pathogenic |
Severe dermatitis-multiple allergies-metabolic wasting syndrome, Severe dermatitis-multiple allergies-metabolic wasting syndrome |
| RS2144108674 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2144110924 |
DSG1
|
Health Risk |
Likely pathogenic |
Palmoplantar keratoderma i, striate |
| RS2144111205 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS2144112404 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144112462 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2144112583 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144112699 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2144112758 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2144113001 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2144113081 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2144113535 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2144114210 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2144115743 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2144115996 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Majeed syndrome |
| RS2144116207 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2144117079 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome, Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome |
| RS2144119000 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2144126463 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2144130282 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144132609 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2144132870 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144133234 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2144133348 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2144134166 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2144134187 |
DHX38
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2144134463 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144134780 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2144134877 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144134987 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS2144135065 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144135103 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2144138527 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144138894 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS2144138948 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS2144139391 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144140268 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS2144141886 |
POLG2
|
Health Risk |
Pathogenic |
— |
| RS2144142389 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS2144143132 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, BBS2-related disorder |
| RS2144143962 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2144145120 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144145429 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144147052 |
G6PC3
|
Health Risk |
Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2144150359 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2144150424 |
MYO5B
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2144150824 |
MYO5B
|
Health Risk |
Pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |